Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Bipolar Disorder Therapeutics Market?
The market size for therapeutics for bipolar disorder has witnessed significant growth in the last few years. An increase from $7.44 billion in 2024 to $7.82 billion in 2025, indicates a Compound Annual Growth Rate (CAGR) of 5.1%. The expansion during the historic period can be related to advancements in medical research, escalated healthcare spending, a surge in mental health disorders, and an increase in patient advocacy.
The market for therapeutics for bipolar disorders is predicted to experience robust development in the forthcoming years. It is forecasted to expand to $9.82 billion by 2029, with a compound annual growth rate (CAGR) of 5.9%. The projected growth in said period can be linked to factors like the rising occurrences of bipolar disorders, governmental initiatives, an expansion of healthcare facilities, and an increase in inactive lifestyle adoption. Key trends anticipated in the forecast period involve customized treatment methodologies, incorporation of digital health, groundbreaking medications, preventive steps, neuroimaging, and biomarkers.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6736&type=smp
What Core Drivers Are Expected To Influence The Bipolar Disorder Therapeutics Market?
The surge in healthcare spending is projected to fuel the expansion of the market for bipolar disorder treatments. Healthcare infrastructure encompasses all financial allocations for healthcare, including medical care costs, preventive measures, public health programs, rehabilitation, community health endeavors, and medical research. The rise in healthcare spending is credited to a few elements, such as an aging demographic, an increase in chronic illnesses, and escalated drug costs that significantly boost the demand for medical services and treatments. As there is increased awareness about mental health concerns, the rate of diagnosis for bipolar disorder escalates, contributing to a rise in demand for therapeutic solutions. For example, in November 2023, as per data from the Canadian Institute for Health Information, a non-profit organization based in Canada, the total healthcare spending in Canada is predicted to grow by 2.8% in 2023, a slight increase from a minimal growth of just 1.5% in 2022. Thus, the upward trend in healthcare spending is a principal driver of growth in the market for bipolar disorder treatments.
What Are The Main Segment Classifications In The Bipolar Disorder Therapeutics Market?
The bipolar disorder therapeuticsmarket covered in this report is segmented –
1) By Drug Class: Mood Stabilizers; Antipsychotic Drugs; Antidepressant Drugs; Other Drugs
2) By Mechanism: Selective Serotonin Reuptake Inhibitors; Serotonin-norepinephrine Reuptake Inhibitors; Tricyclic Antidepressants; Monoamine Oxidase Inhibitors; Benzodiazepines; Beta-Blockers; Other Mechanisms
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Mood Stabilizers: Lithium; Anticonvulsants; Calcium Channel Blockers
2) By Antipsychotic Drugs: Atypical Antipsychotics; Typical Antipsychotics
3) By Antidepressant Drugs: Selective Serotonin Reuptake Inhibitors (SSRIs); Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs); Tricyclic Antidepressants (TCAs)
4) By Other Drugs: Benzodiazepines; Adjunctive Therapies; Herbal Supplements
How Are Industry Trends Steering The Expansion Of The Bipolar Disorder Therapeutics Market?
One significant trend rising in the bipolar disorder therapeutics market is the development of strategic partnerships. To strengthen their standing on the market, several leading firms are turning to collaborations. For example, in April 2022, BioXcel Therapeutics, Inc., an American biopharmaceutical organization, received FDA approval for IGALMITM (dexmedetomidine). This medication, a specially formulated sublingual film that dissolves in the mouth, has been approved for the immediate treatment of agitation linked with schizophrenia or bipolar I or II disorders in adults. It is specifically designed for mild to severe agitation cases in these patient demographics, offering quick effectiveness for managing agitation happenings.
Which Companies Are Contributing Significantly To The Bipolar Disorder Therapeutics Market Growth?
Major companies operating in the bipolar disorder therapeutics market include AbbVie Inc., Pfizer Inc., Astellas Pharma Inc, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC, Januaryssen Pharmaceuticals, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Validus Pharmaceuticals, Eli Lilly and Company, Gedeon Richter PLC., Sumitomo Pharma Co. Ltd, H. Lundbeck A/S, Janssen Pharmaceuticals, Sanofi S.A., Lundbeck A/S, Allergan plc, Takeda Pharmaceutical Company Limited, Sunovion Pharmaceuticals Inc., Alkermes plc, Mylan N.V., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Celon Pharma SA, NeuroRx Inc., IntraCellular Therapies Inc., Sumitomo Pharma Co. Ltd., Vanda Pharmaceuticals Inc., Sage Therapeutics Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report
Which Region Holds The Greatest Opportunity For Bipolar Disorder Therapeutics Market Expansion?
North America was the largest region in the bipolar disorder therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the bipolar disorder therapeutics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=6736&type=smp
Browse Through More Reports Similar to the Global Bipolar Disorder Therapeutics Market 2025, By The Business Research Company
Healthcare Personal Protective Equipment Global Market Report 2025
Healthcare Reimbursement Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/healthcare-reimbursement-global-market-report
Healthcare Service Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/healthcare-service-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model